Síntese de novos fosforamidatos com avitidades ani-HSV-1

Detalhes bibliográficos
Ano de defesa: 2007
Autor(a) principal: Macedo, William Pires de
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Tese
Tipo de acesso: Acesso embargado
Idioma: por
Instituição de defesa: Programa de Pós-graduação em Química Orgânica
Química Orgânica
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: https://app.uff.br/riuff/handle/1/17982
Resumo: The number of the phosphoramidic acid derivatives associated with molecular systems of known biological activity is growing significantly. This is attributed, mainly, to the stability that the compound acquires in physiological environment, when it is incorporated into a phosphoramidic group, toward different enzymatic systems, like the nucleases. Based on a novel antiviral therapeutic concept, an efficient technique was developed, by which phosphoramidic groups are connected to heterocyclic systems with renowned biological activity, after modifications of known methodology for similar reactions. Herein, heterocyclic substrates such as 4-chloro-pirazolo[3,4-b]pyridine, 4-chloro-quinoline and 4-choloro-thieno[2,3-b]pyridine were phosphorylated by aminoalkyl phosphoramidic acid esters, generating three new phosphoramidate derivatives of series 60, 61 and 62,respectively.The products of the three series were obtained in good yield and tested against HSV-1 virus.